UBS AM’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.58M | Sell |
|
|||||
|
2025
Q2 | $11.2M | Buy |
|
|||||
|
2025
Q1 | $10.6M | Buy |
|
|||||
|
2024
Q4 | $9.67M | Sell |
|
|||||
|
2024
Q3 | $16M | Sell |
|
|||||
|
2024
Q2 | $14.3M | Buy |
|
|||||
|
2024
Q1 | $2.05M | Sell |
|
|||||
|
2023
Q4 | $825K | Hold |
|
|||||
|
2023
Q3 | $582K | Buy |
|
|||||
|
2023
Q2 | $864K | Hold |
|
|||||
|
2023
Q1 | $864K | Sell |
|
|||||
|
2022
Q4 | $1.34M | Buy |
|
|||||
|
2022
Q3 | $387K | Hold |
|
|||||
|
2022
Q2 | $345K | Hold |
|
|||||
|
2022
Q1 | $438K | Sell |
|
|||||
|
2021
Q4 | $791K | Buy |
|
|||||
|
2021
Q3 | $235K | Buy |
|